New Collaboration Intended to Advance Drug Discovery Methods.MADISON, Wis. -- Promega Corporation is proud to announce a collaboration agreement with the Guangzhou Institute of Biomedicine biomedicine /bio·med·i·cine/ (bi?o-med´i-sin) clinical medicine based on the principles of the natural sciences (biology, biochemistry, etc.).biomed´ical bi·o·med·i·cine n. 1. and Health (GIBH), Chinese Academy of Sciences The Chinese Academy of Sciences (CAS) (Simplified Chinese: 中国科学院; Pinyin: Zhōngguó Kēxuéyuàn), formerly known as Academia Sinica . The agreement is designed to co-develop compound profiling solutions for small molecule and traditional Chinese medicine Traditional Chinese Medicine Definition Traditional Chinese medicine (TCM) is an ancient and still very vital holistic system of health and healing, based on the notion of harmony and balance, and employing the ideas of moderation and prevention. drug screening. By combing the drug discovery expertise of GIBH with the biological assay expertise of Promega, the partnership is intended to deliver turnkey services to pharmaceutical companies interested in speeding up their lead discovery and lead optimization processes. GIBH scientists will offer contract services designed to profile the biology of potential leads using the Promega suite of biological drug screening assays. Initial plans call for development of Cytochrome cytochrome (sī`təkrōm'), protein containing heme (see coenzyme) that participates in the phase of biochemical respiration called oxidative phosphorylation. P450, Cytotoxicity cytotoxicity /cy·to·tox·ic·i·ty/ (si?to-tok-sis´i-te) the degree to which an agent possesses a specific destructive action on certain cells or the possession of such action. , Kinase and GPCR GPCR Guanine Nucleotide-Binding Protein-Coupled Receptor GPCR GTP-binding Protein-Coupled Receptor profiling assays. GIBH will use the assays both in house for own discovery programs as well as offer them on a contract basis to outside companies. About Promega Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 1,450 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 12 countries and 54 global distributors. Annual sales exceed $190 million. For more information about Promega, visit www.promega.com. About GIBH Guangzhou Institute of Biomedicine and Health (GIBH), Chinese Academy of Sciences, established from scratch since 2004, is the first integrated research organization that focuses on translational research and drug discovery in China. It has four disease-focused research areas which include: Infectious Diseases infectious diseases: see communicable diseases. , Cancers, Metabolic Diseases and Cardiovascular Diseases. Recently, the institute has launched a new research center for regenerative medicine and stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. . The mission of GIBH is to improve the health of the general public through promoting innovative research and integrating key technologies to facilitate the development of novel medicines. Most of its senior investigators received their education and training abroad. GIBH welcomes collaborations with various pharmaceutical companies and other related research institutions. For more information about GIBH, please visit the website: www.gibh.ac.cn |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion